SARAH HUMES: Open Payments
NPI 1962902254 · SOUTH BEND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,938 in 112 payments from 16 companies in 2025. Trend: 2023 $1,657 · 2024 $1,376 · 2025 $1,938
Food & beverage: $1,810Education: $128
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $472 |
| Galderma Laboratories, L.P. | 21 | $347 |
| Janssen Biotech, Inc. | 9 | $219 |
| GENZYME CORPORATION | 6 | $149 |
| Novartis Pharmaceuticals Corporation | 9 | $146 |
| Organon LLC | 7 | $118 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $101 |
| Incyte Corporation | 4 | $98 |
| Lilly USA, LLC | 4 | $78 |
| Regeneron Healthcare Solutions, Inc. | 3 | $74 |
Products named: SKYRIZI, NEMLUVIO, DUPIXENT, TREMFYA, RINVOQ, AKLIEF, ILUMYA, OPZELURA.
Industry payments across IN — which companies pay providers there.
